Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Zinah K. Al-Qaysi, Ian G. Beadham, Sianne L. Schwikkard, Joseph C. Bear, Ali A. Al-Kinani & Raid G. Alany. (2023) Sustained release ocular drug delivery systems for glaucoma therapy. Expert Opinion on Drug Delivery 20:7, pages 905-919.
Read now
Read now
Christina Scelfo, Reem H. ElSheikh, Muhammad M. Shamim, Javaneh Abbasian, Alireza Ghaffarieh & Abdelrahman M. Elhusseiny. (2023) Ocular Surface Disease in Glaucoma Patients. Current Eye Research 48:3, pages 219-230.
Read now
Read now
Aditya Belamkar, Alon Harris, Ryan Zukerman, Brent Siesky, Francesco Oddone, Alice Verticchio Vercellin & Thomas A. Ciulla. (2022) Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications. Annals of Medicine 54:1, pages 343-358.
Read now
Read now
Kangmin Lee, Gahye Lee, Soomin Lee & Choul Yong Park. (2022) Advances in ophthalmic drug delivery technology for postoperative management after cataract surgery. Expert Opinion on Drug Delivery 19:8, pages 945-964.
Read now
Read now
Jie Zhang, Jinghua Jiao, Meng Niu, Xiaotong Gao, Guisen Zhang, Honghua Yu, Xiaohong Yang & Lei Liu. (2021) Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective. International Journal of Nanomedicine 16, pages 6497-6530.
Read now
Read now
Prakash K. Soni & T. R. Saini. (2021) Formulation design and optimization of cationic-charged liposomes of brimonidine tartrate for effective ocular drug delivery by design of experiment (DoE) approach. Drug Development and Industrial Pharmacy 47:11, pages 1847-1866.
Read now
Read now
José Javier López-Cano, Miriam Ana González-Cela-Casamayor, Vanessa Andrés-Guerrero, Rocío Herrero-Vanrell & Irene Teresa Molina-Martínez. (2021) Liposomes as vehicles for topical ophthalmic drug delivery and ocular surface protection. Expert Opinion on Drug Delivery 18:7, pages 819-847.
Read now
Read now
Arindam Halder & Ajay J Khopade. (2020) Physiochemical Properties and Cytotoxicity of a Benzalkonium Chloride-Free, Micellar Emulsion Ophthalmic Formulation of Latanoprost. Clinical Ophthalmology 14, pages 3057-3064.
Read now
Read now
Song Kwon, Sung Hyun Kim, Dongwoo Khang & Jong Yeon Lee. (2020) Potential Therapeutic Usage of Nanomedicine for Glaucoma Treatment. International Journal of Nanomedicine 15, pages 5745-5765.
Read now
Read now
Dina Fathalla, Ehab A. Fouad & Ghareb M. Soliman. (2020) Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma. Drug Development and Industrial Pharmacy 46:5, pages 806-813.
Read now
Read now
Shuangyan Tian, Juan Li, Qi Tao, Yawen Zhao, Zhufen Lv, Fan Yang, Haoyun Duan, Yanzhong Chen, Qingjun Zhou & Dongzhi Hou. (2018) Controlled drug delivery for glaucoma therapy using montmorillonite/Eudragit microspheres as an ion-exchange carrier. International Journal of Nanomedicine 13, pages 415-428.
Read now
Read now
Jennifer J. Kang-Mieler, Emily Dosmar, Wenqiang Liu & William F. Mieler. (2017) Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications. Expert Opinion on Drug Delivery 14:5, pages 611-620.
Read now
Read now
Andrei-Alexandru Szigiato, Dominik W. Podbielski & Iqbal Ike K. Ahmed. (2017) Sustained drug delivery for the management of glaucoma. Expert Review of Ophthalmology 12:2, pages 173-186.
Read now
Read now
Renu Agarwal, Igor Iezhitsa, Puneet Agarwal, Nurul Alimah Abdul Nasir, Norhafiza Razali, Renad Alyautdin & Nafeeza Mohd Ismail. (2016) Liposomes in topical ophthalmic drug delivery: an update. Drug Delivery 23:4, pages 1075-1091.
Read now
Read now
Jed Asher Lusthaus & Ivan Goldberg. (2016) Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors. Expert Opinion on Emerging Drugs 21:1, pages 117-128.
Read now
Read now
Articles from other publishers (14)
Eloy Pena-Rodríguez, Laura García-Vega, Maria Lajarin Reinares, Marçal Pastor-Anglada, Sandra Pérez-Torras & Francisco Fernandez-Campos. (2022) Latanoprost-Loaded Nanotransfersomes Designed for Scalp Administration Enhance Keratinocytes Proliferation. Molecular Pharmaceutics 20:5, pages 2317-2325.
Crossref
Crossref
Phatsawee Jansook & Thorsteinn Loftsson. (2022) Aqueous Prostaglandin Eye Drop Formulations. Pharmaceutics 14:10, pages 2142.
Crossref
Crossref
Miriam Ana González-Cela-Casamayor, José Javier López-Cano, Irene Bravo-Osuna, Vanessa Andrés-Guerrero, Marta Vicario-de-la-Torre, Manuel Guzmán-Navarro, José Manuel Benítez-del-Castillo, Rocío Herrero-Vanrell & Irene Teresa Molina-Martínez. (2022) Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma Treatment. Pharmaceutics 14:7, pages 1405.
Crossref
Crossref
Bharti Gupta, Varsha Mishra, Sankalp Gharat, Munira Momin & Abdelwahab Omri. (2021) Cellulosic Polymers for Enhancing Drug Bioavailability in Ocular Drug Delivery Systems. Pharmaceuticals 14:11, pages 1201.
Crossref
Crossref
Onyinye J. Uwaezuoke, Pradeep Kumar, Viness Pillay & Yahya E. Choonara. (2021) Fouling in ocular devices: implications for drug delivery, bioactive surface immobilization, and biomaterial design. Drug Delivery and Translational Research 11:5, pages 1903-1923.
Crossref
Crossref
Patrick M. Hughes & Jie Shen. 2021. Ophthalmic Product Development. Ophthalmic Product Development
15
37
.
Paul L. Chariou, Oscar A. Ortega-Rivera & Nicole F. Steinmetz. (2020) Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients. ACS Nano 14:3, pages 2678-2701.
Crossref
Crossref
Abhishek K. Sah, Nagendra Bhuwane, Ishwari Choudhary, Shweta Ramkar & Preeti K. Suresh. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health
207
226
.
Eliana B. Souto, João Dias-Ferreira, Ana López-Machado, Miren Ettcheto, Amanda Cano, Antonio Camins Espuny, Marta Espina, Maria Luisa Garcia & Elena Sánchez-López. (2019) Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents. Pharmaceutics 11:9, pages 460.
Crossref
Crossref
O. A. Kiseleva, A. M. Bessmertny & L. V. Yakubova. (2018) New technologies of hypotensive drug delivery in glaucoma treatment. Russian Ophthalmological Journal 11:4, pages 103-107.
Crossref
Crossref
Fazhan Wang, Xingting Bao, Aiping Fang, Huili Li, Yang Zhou, Yongmei Liu, Chunling Jiang, Jinhui Wu & Xiangrong Song. (2018) Nanoliposome-Encapsulated Brinzolamide-hydropropyl-β-cyclodextrin Inclusion Complex: A Potential Therapeutic Ocular Drug-Delivery System. Frontiers in Pharmacology 9.
Crossref
Crossref
Joanne D. Du, Wye-Khay Fong, Suzanne Caliph & Ben J. Boyd. (2016) Lipid-based drug delivery systems in the treatment of wet age-related macular degeneration. Drug Delivery and Translational Research 6:6, pages 781-792.
Crossref
Crossref
Andri K. Riau, Debasish Mondal, Thet T. Aung, Elavazhagan Murugan, Liyan Chen, Nyein C. Lwin, Lei Zhou, Roger W. Beuerman, Bo Liedberg, Subbu S. Venkatraman & Jodhbir S. Mehta. (2015) Collagen-Based Artificial Corneal Scaffold with Anti-Infective Capability for Prevention of Perioperative Bacterial Infections. ACS Biomaterials Science & Engineering 1:12, pages 1324-1334.
Crossref
Crossref
Tina T. Wong, Gary D. Novack, Jayaganesh V. Natarajan, Ching Lin Ho, Hla M. Htoon & Subbu S. Venkatraman. (2014) Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops. Drug Delivery and Translational Research 4:4, pages 303-309.
Crossref
Crossref